APA

Khanani A. M., Gahn G. M., Koci M. M., Dang J. M., Brown S. M. & Hill L. F. (2019). Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better. : Clinical ophthalmology (Auckland, N.Z.).

Chicago

Khanani Arshad M, Gahn Greggory M, Koci Micaela M, Dang Jonathan M, Brown Sandra M and Hill Lauren F. 2019. Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better. : Clinical ophthalmology (Auckland, N.Z.).

Harvard

Khanani A. M., Gahn G. M., Koci M. M., Dang J. M., Brown S. M. and Hill L. F. (2019). Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better. : Clinical ophthalmology (Auckland, N.Z.).

MLA

Khanani Arshad M, Gahn Greggory M, Koci Micaela M, Dang Jonathan M, Brown Sandra M and Hill Lauren F. Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better. : Clinical ophthalmology (Auckland, N.Z.). 2019.